250 related articles for article (PubMed ID: 17629842)
1. Enzymatic synthesis of glycosaminoglycan heparin.
Linhardt RJ; Dordick JS; Deangelis PL; Liu J
Semin Thromb Hemost; 2007 Jul; 33(5):453-65. PubMed ID: 17629842
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic Synthesis of Glycosaminoglycans.
Zhang X; Lin L; Huang H; Linhardt RJ
Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
[TBL] [Abstract][Full Text] [Related]
3. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
4. Recent progress and applications in glycosaminoglycan and heparin research.
Laremore TN; Zhang F; Dordick JS; Liu J; Linhardt RJ
Curr Opin Chem Biol; 2009 Dec; 13(5-6):633-40. PubMed ID: 19781979
[TBL] [Abstract][Full Text] [Related]
5. Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides.
Karst NA; Linhardt RJ
Curr Med Chem; 2003 Oct; 10(19):1993-2031. PubMed ID: 12871100
[TBL] [Abstract][Full Text] [Related]
6. Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides: 2000-Present.
Dulaney SB; Huang X
Adv Carbohydr Chem Biochem; 2021; 80():121-164. PubMed ID: 34872655
[TBL] [Abstract][Full Text] [Related]
7. Bioengineered production of glycosaminoglycans and their analogues.
Jin W; Zhang F; Linhardt RJ
Syst Microbiol Biomanuf; 2021 Apr; 1(2):123-130. PubMed ID: 38524245
[TBL] [Abstract][Full Text] [Related]
8. Bioengineered heparins and heparan sulfates.
Fu L; Suflita M; Linhardt RJ
Adv Drug Deliv Rev; 2016 Feb; 97():237-49. PubMed ID: 26555370
[TBL] [Abstract][Full Text] [Related]
9. [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].
Alban S
Hamostaseologie; 2008 Feb; 28(1-2):51-61. PubMed ID: 18278163
[TBL] [Abstract][Full Text] [Related]
10. One-Pot Enzymatic Synthesis of Heparin from N-Sulfoheparosan.
Fu L; Linhardt RJ
Methods Mol Biol; 2022; 2303():3-11. PubMed ID: 34626365
[TBL] [Abstract][Full Text] [Related]
11. Current state on the enzymatic synthesis of glycosaminoglycans.
Gottschalk J; Elling L
Curr Opin Chem Biol; 2021 Apr; 61():71-80. PubMed ID: 33271474
[TBL] [Abstract][Full Text] [Related]
12. Heparin and heparan sulfate: biosynthesis, structure and function.
Sasisekharan R; Venkataraman G
Curr Opin Chem Biol; 2000 Dec; 4(6):626-31. PubMed ID: 11102866
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Xylosides: Probing the Glycosaminoglycan Biosynthetic Machinery for Biomedical Applications.
Chua JS; Kuberan B
Acc Chem Res; 2017 Nov; 50(11):2693-2705. PubMed ID: 29058876
[TBL] [Abstract][Full Text] [Related]
14. Synthetic heparin and heparan sulfate: probes in defining biological functions.
Tsai CT; Zulueta MML; Hung SC
Curr Opin Chem Biol; 2017 Oct; 40():152-159. PubMed ID: 29032302
[TBL] [Abstract][Full Text] [Related]
15. New Applications of Heparin and Other Glycosaminoglycans.
Lima M; Rudd T; Yates E
Molecules; 2017 May; 22(5):. PubMed ID: 28481236
[TBL] [Abstract][Full Text] [Related]
16. Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
Zhou Z; Zhang L; Wu X; Luo L; Wu J; Xu D; Wu M
Eur J Med Chem; 2022 Apr; 234():114256. PubMed ID: 35279609
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.
Koenig A; Norgard-Sumnicht K; Linhardt R; Varki A
J Clin Invest; 1998 Feb; 101(4):877-89. PubMed ID: 9466983
[TBL] [Abstract][Full Text] [Related]
18. Heparin/heparan sulphate-based drugs.
Gandhi NS; Mancera RL
Drug Discov Today; 2010 Dec; 15(23-24):1058-69. PubMed ID: 20974281
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
20. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
